US2006237024A1PendingUtilityA1

Tobacco product labeling system

Assignee: REICH SUSANPriority: Oct 2, 2003Filed: Mar 30, 2006Published: Oct 26, 2006
Est. expiryOct 2, 2023(expired)· nominal 20-yr term from priority
A24B 15/10A24C 5/601A24D 1/025A24D 1/16A24B 15/20A24D 1/002A24B 15/243A24B 15/245A24B 3/12
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosed invention relates to visual content indicators of a tobacco product. More specifically, the invention includes labeling systems that provide at least one visual indicator of a tobacco product, methods for using the systems, and tobacco products that display one or more visual indicators of content. The present invention generally relates to tobacco products, which have a reduced amount of nicotine and tobacco specific nitrosamines (TSNAs), and contain one or more nicotine substitutes. The use of these tobacco products to reduce the exposure of an individual to nicotine, as well as, facilitating tobacco-use cessation is disclosed.

Claims

exact text as granted — not AI-modified
1 . A cigarette labeled with a visual content indicator, wherein the visual content indicator identifies the amount of a compound of the cigarette.  
   
   
       2 . The cigarette of  claim 1 , wherein the compound is nicotine.  
   
   
       3 . The cigarette of  claim 1 , wherein the visual indicator is a number.  
   
   
       4 . The cigarette of  claim 1 , wherein the visual indicator is a color.  
   
   
       5 . The cigarette of  claim 1 , wherein the compound is a carcinogen.  
   
   
       6 . The cigarette of  claim 1 , wherein the visual indicator is a symbol.  
   
   
       7 . The cigarette of  claim 1 , wherein the visual indicator is a letter.  
   
   
       8 . The cigarette of  claim 1 , wherein the compound is a nicotine substitute.  
   
   
       9 . A tobacco use cessation program comprising a cigarette that comprises a visual indicator of the amount of nicotine.  
   
   
       10 . The tobacco use cessation program of  claim 9 , wherein the program comprises a first cigarette with a visual indicator that denotes reduced nicotine and a second cigarette with a visual indicator that denotes essentially nicotine-free.  
   
   
       11 . The tobacco use cessation program of  claim 9 , wherein the visual indicator is a number.  
   
   
       12 . The tobacco use cessation program of  claim 10 , wherein the visual indicators on the said first and said second cigarettes are numbers.  
   
   
       13 . A cigarette comprising a tobacco and a nicotine substitute.  
   
   
       14 . The cigarette of  claim 13 , wherein said tobacco is genetically modified.  
   
   
       15 . The cigarette of  claim 14 , wherein the tobacco comprises a reduced amount of nicotine as compared to a conventional tobacco of the same variety.  
   
   
       16 . The cigarette of  claim 14 , wherein the nicotine substitute is Cytisine.  
   
   
       17 . This cigarette of  claim 14 , wherein the cigarette is labeled with a visual content indicator, wherein the visual content indicator identifies the amount of a compound of the cigarette.  
   
   
       18 . The cigarette of  claim 17 , wherein the compound is nicotine.  
   
   
       19 . The cigarette of  claim 17 , wherein the compound is a nicotine substitute  
   
   
       20 . A tobacco use cessation program comprising a modified tobacco product, wherein said modified tobacco product comprises a modified tobacco that has less nicotine than a tobacco of the same variety and a nicotine substitute.  
   
   
       21 . The tobacco use cessation program of  claim 20 , wherein said tobacco product further comprises a visual content indicator, wherein the visual content indicator identifies the amount of a compound of the tobacco product.  
   
   
       22 . The tobacco use cession program of  claim 20 , wherein said tobacco is a genetically modified tobacco.  
   
   
       23 . The tobacco use cessation program of  claim 20 , wherein said genetically modified tobacco is a Virginia Flue tobacco.  
   
   
       24 . The tobacco use cessation program of  claim 20 , wherein said genetically modified tobacco is an Oriental tobacco.  
   
   
       25 . The tobacco use cessation program of  claim 20 , wherein said genetically modified tobacco is an a Burley tobacco.  
   
   
       26 . The tobacco use cessation program of  claim 20 , wherein said modified tobacco comprises 0.6 mg of nicotine or less.  
   
   
       27 . The tobacco use cessation program of  claim 20 , wherein said modified tobacco comprises 0.3 mg of nicotine or less.  
   
   
       28 . The tobacco use cessation program of  claim 20 , wherein said modified tobacco comprises 0.05 mg of nicotine or less.  
   
   
       29 . The tobacco use cessation program of  claim 20 , wherein said nicotine substitute is Cytisine.  
   
   
       30 . The tobacco use cessation program of  claim 20 , wherein said tobacco product is a cigarette.  
   
   
       31 . The tobacco use cessation program of  claim 30 , wherein said nicotine substitute is added to the paper of said cigarette.  
   
   
       32 . The tobacco use cessation program of  claim 30 , wherein said nicotine substitute is added to a filter of said tobacco product.  
   
   
       33 . The tobacco use cessation program of  claim 20 , wherein said nicotine substitute Cytisine is a receptor binding nicotine substitute.  
   
   
       34 . The tobacco use cessation program of  claim 20 , wherein said tobacco product comprises an amount of Cytisine that is sufficient to deliver less than 2.0 mg of Cytisine to a consumer.  
   
   
       35 . The tobacco use cessation program of  claim 20 , wherein said tobacco product comprises an amount of Cytisine that is sufficient to deliver less than 1.5 mg of Cytisine to a consumer.  
   
   
       36 . The tobacco use cessation program of  claim 20 , wherein said tobacco product comprises an amount of Cytisine that is sufficient to deliver less than 1.0 mg of Cytisine to a consumer.  
   
   
       37 . The tobacco use cessation program of  claim 20 , wherein said tobacco product comprises an amount of Cytisine that is sufficient to deliver less than 0.5 mg of Cytisine to a consumer.  
   
   
       38 . A method of reducing the exposure of a tobacco consumer to nicotine comprising: 
 providing to said tobacco consumer a tobacco product comprising a modified tobacco that has less nicotine than tobacco of the same variety, and a nicotine substitute.    
   
   
       39 . The method of  claim 38 , wherein said tobacco product further comprises a visual content indicator, wherein the visual content indicator identifies the amount of a compound of the tobacco product.  
   
   
       40 . The method of  claim 38 , wherein said modified tobacco is a Burley tobacco.  
   
   
       41 . The method of  claim 38 , wherein said modified tobacco is a Virginia Flue tobacco.  
   
   
       42 . The method of  claim 38 , wherein said modified tobacco is an Oriental tobacco.  
   
   
       43 . The method of  claim 38 , wherein said modified tobacco is a genetically modified tobacco.  
   
   
       44 . The method of  claim 38 , wherein said modified tobacco comprises 0.6 mg of nicotine or less.  
   
   
       45 . The method of  claim 38 , wherein said modified tobacco comprises 0.3 mg of nicotine or less.  
   
   
       46 . The method of  claim 38 , wherein said modified tobacco comprises 0.05 mg of nicotine or less.  
   
   
       47 . The method of  claim 38 , wherein said nicotine substitute is Cytisine.  
   
   
       48 . The method of  claim 38 , wherein said tobacco product is a cigarette.

Join the waitlist — get patent alerts

Track US2006237024A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.